Erratum: Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial (Am J Gastroenterol (2010) 105 (2276-2286) DOI:10.1038/ajg.2010.201)

American Journal of Gastroenterology

Volumn 106, Issue 6, 2011, Pages 1177-1178

  Whitcomb, David C ^a   Lehman, Glen A ^a   Vasileva, Galina ^a   Malecka Panas, Ewa ^a   Gubergrits, Natalya ^a   Shen, Yannan ^a   Sander Struckmeier, Suntje ^a   Caras, Steven ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 79958019486     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.151     Document Type: Erratum

References (2)

1. Trapnell BC, Maguiness K, Graff GR et al. Effi cacy and safety of Creon ® 24,000 in subjects with exocrine pancreatic insuffi ciency due to cystic fi brosis. J Cyst Fibros 2009; 8: 370-7.
2. Graff GR, Maguiness K, McNamara J et al. Effi cacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7- 11 years with exocrine pancreatic insuffi ciency and cystic fi brosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Clin Ther 2010; 32: 89-103.